54-86-4

Basic information

• Product Name: SODIUM NICOTINATE
• Synonyms: natriumnicotinat;NICOTINIC ACID SODIUM SALT;PYRIDINE-3-CARBOXYLIC ACID SODIUM SALT;SODIUM NICOTINATE;SODIUM PYRIDINE-3-CARBOXYLATE;Sodiumnicotinate,98%;Niacin, sodium salt;Nicotinate Acid
• CAS NO: 54-86-4
• Molecular Formula: C₆H₄NO₂*Na
• Molecular Weight: 145.09
• EINECS: 200-215-1
• Product Categories: Vitamin Ingredients;C6;Heterocyclic Building Blocks;Pyridines
• Mol File: 54-86-4.mol
• Article Data: 4

Chemical Properties

• Melting Point: >300℃
• Boiling Point: 292.5°Cat760mmHg
• Flash Point: 130.7°C
• Appearance: /
• Density: 1.293g/cm³
• Vapor Pressure: 0.000836mmHg at 25°C
• CAS DataBase Reference: SODIUM NICOTINATE(CAS DataBase Reference)
• NIST Chemistry Reference: SODIUM NICOTINATE(54-86-4)
• EPA Substance Registry System: SODIUM NICOTINATE(54-86-4)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-37/39
• WGK Germany: 3
• RTECS: QT2060000
• TSCA: Yes
• Hazardous Substances Data: 54-86-4(Hazardous Substances Data)

Usage

Description

SODIUM NICOTINATE, also known as nicotinic acid sodium salt, is a crystalline powder that serves as an intermediate in the cosmetic and pharmaceutical industries. It is derived from nicotinic acid, which is a form of vitamin B3, and is known for its various beneficial properties.

Uses

Used in Pharmaceutical Industry:
SODIUM NICOTINATE is used as an intermediate for the development of various pharmaceutical products. It plays a crucial role in the synthesis of medications that target a wide range of health conditions, including cardiovascular diseases and skin disorders.
Used in Cosmetic Industry:
SODIUM NICOTINATE is used as an active ingredient in the cosmetic industry for its skin-beneficial properties. It is commonly utilized in the formulation of skincare products, such as creams, lotions, and serums, due to its ability to improve skin health and appearance.

InChI:InChI=1/C6H5NO2.Na/c8-6(9)5-2-1-3-7-4-5;/h1-4H,(H,8,9);/q;+1/p-1

Upstream product

• 93-60-7 methyl 3-pyridinecarboxylate 
• 59-67-6 nicotinic acid 
• 5657-61-4 nicotinyl hydroxamic acid 

Downstream Products

• 10400-19-8 3-pyridinecarbonyl chloride 
• 66148-15-0 d4-nicotinic acid 
• 120155-05-7 7-benzyloxy-6-methoxy-1-methylene-2-nicotinyl-1,2,3,4-tetrahydroisoquinoline 
• 120155-02-4 11-benzyloxy-10-methoxy-7,8-dihydro-5H-benzopyrido<3,2-g>quinolizin-5-one 
• 104669-20-7 11-benzyloxy-10-methoxy-7,8-dihydro-5H-benzopyrido<3,4-g>quinolizin-5-one 
• 115757-50-1 11-benzyloxy-10-methoxy-7,8-dihydro-5H-benzopyrido<3,4-g>quinolizin-5-thione 
• 94-44-0 benzyl nicotinate 
• 16230-63-0 copper(II) nicotinate 
• 1260234-99-8 C₁₉H₁₅N₅O₃S 
• 7681-15-4 n-propyl nicotinate 
• 28558-40-9 2-oxo-2-phenylethyl riicotinate 
• 86535-76-4 3-phenyl-1-(pyridin-3-yl)prop-2-yn-1-one 
• 1450824-31-3 4-(2-(3-pyridylformyloxy)ethoxy)-3-phenylfuran-2(5H)-one 
• 1537179-03-5 (S)-tert-butyl-2-(nicotinamido)-3-phenylpropanoate 

Relevant articles and documents

Hydrogen bonds determine the signal arrangement in 13C NMR spectra of nicotinate

Present work reports on studies of sodium nicotinate solutions in water and aqueous ethanol by means of 1H, 13C, 15N NMR spectroscopy. The H(2) nucleus was observed to be the least shielded among pyridine ring protons whil

HDL-boosting combination therapy complexes

A pharmaceutical composition including therapeutically effective amounts of at least one HMG-CoA reductase inibitor present as a dyhydroxyacid salt and at least one additional therapeutic agent.